Additionally, a distinct correlation was observed between ADAR1 expression and the stromal cell marker CLDN5 in blood endothelial cells (BECs) and lymphatic endothelial cells (LECs), providing a refined perspective on ADAR1’s role across various cancer types (8). This evidence concerns the gene CLDN5 and cancer.